The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ito, T.
Right arrow Articles by Fukuhara, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ito, T.
Right arrow Articles by Fukuhara, S.
The Journal of Immunology, 2004, 172: 4253-4259.
Copyright © 2004 by The American Association of Immunologists

Plasmacytoid Dendritic Cells Regulate Th Cell Responses through OX40 Ligand and Type I IFNs1

Tomoki Ito*, Ryuichi Amakawa2,*, Muneo Inaba{dagger}, Toshiyuki Hori{ddagger}, Maiko Ota*, Kengo Nakamura*, Masashi Takebayashi*, Michihiko Miyaji*, Tomoo Yoshimura§, Kayo Inaba and Shirou Fukuhara*

* First Department of Internal Medicine, Kansai Medical University, Osaka, Japan; {dagger} First Department of Pathology, Kansai Medical University, Osaka, Japan; {ddagger} First Department of Internal Medicine, Kyoto University, Kyoto, Japan; § Department of Obstetrics and Gynecology, Kansai Medical University, Osaka, Japan; and Department of Animal Development and Physiology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan

Dendritic cells (DCs) show a functional plasticity in determining Th responses depending on their maturational stage or on maturational signals delivered to the DCs. Human plasmacytoid DCs (PDCs) can induce either Th1- or Th2-type immune responses upon exposure to viruses or IL-3, respectively. In this study we have investigated the Th-polarizing capacity of PDCs after short (24-h) or long (72-h) culture with stimuli and have assessed the expression and function of OX40 ligand (OX40L) in PDC-mediated Th polarization in addition to type I IFN-dependent responses. IL-3-treated PDCs expressed OX40L, but produced almost no IFN-{alpha} in response to T cell stimulation (CD40 ligand or T cell interaction), resulting in the preferential priming of Th2 cells through OX40L-dependent mechanisms. Meanwhile, PDCs were rapidly endowed by viral infection (Sendai virus) with a high potency to develop IFN-{gamma}-producing Th cells depending on their capacity to residually produce IFN-{alpha}. Although Sendai virus-stimulated PDCs simultaneously expressed OX40L in their maturational process, the Th1-inducing effect of endogenous type I IFNs may overcome and thus conceal the OX40L-dependent Th2 responses. However, during maturation in response to Sendai virus over the longer 72-h period, the expression level of OX40L was up-regulated, whereas the residual IFN-{alpha}-producing ability was down-regulated, and consequently, the PDCs with prolonged Sendai virus stimulation induced Th2 responses to some extent. Thus, PDCs have the distinct means to dictate an appropriate response to environmental stimuli.




This article has been cited by other articles:


Home page
Eur Respir JHome page
C-H. Hung, Y-T. Chu, J-L. Suen, M-S. Lee, H-W. Chang, Y-C. Lo, and Y-J. Jong
Regulation of cytokine expression in human plasmacytoid dendritic cells by prostaglandin I2 analogues
Eur. Respir. J., February 1, 2009; 33(2): 405 - 410.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. K. Pfaller and K.-K. Conzelmann
Measles Virus V Protein Is a Decoy Substrate for I{kappa}B Kinase {alpha} and Prevents Toll-Like Receptor 7/9-Mediated Interferon Induction
J. Virol., December 15, 2008; 82(24): 12365 - 12373.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Bjorck, A. Beilhack, E. I. Herman, R. S. Negrin, and E. G. Engleman
Plasmacytoid Dendritic Cells Take Up Opsonized Antigen Leading to CD4+ and CD8+ T Cell Activation In Vivo
J. Immunol., September 15, 2008; 181(6): 3811 - 3817.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Li, S. Liu, T. Zhang, W. Pan, X. Yang, and X. Cao
Splenic Stromal Microenvironment Negatively Regulates Virus-Activated Plasmacytoid Dendritic Cells through TGF-{beta}
J. Immunol., March 1, 2008; 180(5): 2951 - 2956.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
V. Veckman and I. Julkunen
Streptococcus pyogenes activates human plasmacytoid and myeloid dendritic cells
J. Leukoc. Biol., February 1, 2008; 83(2): 296 - 304.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
K. Takahashi, S. Satoi, H. Yanagimoto, N. Terakawa, H. Toyokawa, T. Yamamoto, Y. Matsui, S. Takai, A-H. Kwon, and Y. Kamiyama
Circulating Dendritic Cells and Development of Septic Complications After Pancreatectomy for Pancreatic Cancer
Arch Surg, December 1, 2007; 142(12): 1151 - 1157.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. Ito, M. Yang, Y.-H. Wang, R. Lande, J. Gregorio, O. A Perng, X.-F. Qin, Y.-J. Liu, and M. Gilliet
Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand
J. Exp. Med., January 22, 2007; 204(1): 105 - 115.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Kurooka and Y. Kaneda
Inactivated Sendai Virus Particles Eradicate Tumors by Inducing Immune Responses through Blocking Regulatory T Cells
Cancer Res., January 1, 2007; 67(1): 227 - 236.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. J. Popovic, R. DeMarco, M. T. Lotze, S. E. Winikoff, D. L. Bartlett, A. M. Krieg, Z. S. Guo, C. K. Brown, K. J. Tracey, and H. J. Zeh III
High Mobility Group B1 Protein Suppresses the Human Plasmacytoid Dendritic Cell Response to TLR9 Agonists
J. Immunol., December 15, 2006; 177(12): 8701 - 8707.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Allman, M. Dalod, C. Asselin-Paturel, T. Delale, S. H. Robbins, G. Trinchieri, C. A. Biron, P. Kastner, and S. Chan
Ikaros is required for plasmacytoid dendritic cell differentiation
Blood, December 15, 2006; 108(13): 4025 - 4034.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. J. Masten, G. K. Olson, C. A. Tarleton, C. Rund, M. Schuyler, R. Mehran, T. Archibeque, and M. F. Lipscomb
Characterization of Myeloid and Plasmacytoid Dendritic Cells in Human Lung
J. Immunol., December 1, 2006; 177(11): 7784 - 7793.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Kitawaki, N. Kadowaki, N. Sugimoto, N. Kambe, T. Hori, Y. Miyachi, T. Nakahata, and T. Uchiyama
IgE-activated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells
Int. Immunol., December 1, 2006; 18(12): 1789 - 1799.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. J. Montoya, H.-B. Jie, L. Al-Harthi, C. Mulder, P. J. Patino, M. T. Rugeles, A. M. Krieg, A. L. Landay, and S. B. Wilson
Activation of Plasmacytoid Dendritic Cells with TLR9 Agonists Initiates Invariant NKT Cell-Mediated Cross-Talk with Myeloid Dendritic Cells
J. Immunol., July 15, 2006; 177(2): 1028 - 1039.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. Mima, S. Yamamoto, M. Ito, R. Tomoshige, Y. Tabata, K. Tamai, and Y. Kaneda
Targeted chemotherapy against intraperitoneally disseminated colon carcinoma using a cationized gelatin-conjugated HVJ envelope vector.
Mol. Cancer Ther., April 1, 2006; 5(4): 1021 - 1028.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Agostini, E. Cenci, E. Pericolini, G. Nocentini, G. Bistoni, A. Vecchiarelli, and C. Riccardi
The Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related Gene Modulates the Response to Candida albicans Infection
Infect. Immun., November 1, 2005; 73(11): 7502 - 7508.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Bendriss-Vermare, S. Burg, H. Kanzler, L. Chaperot, T. Duhen, O. de Bouteiller, M. D'agostini, J.-M. Bridon, I. Durand, J. M. Sederstrom, et al.
Virus overrides the propensity of human CD40L-activated plasmacytoid dendritic cells to produce Th2 mediators through synergistic induction of IFN-{gamma} and Th1 chemokine production
J. Leukoc. Biol., October 1, 2005; 78(4): 954 - 966.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Morita, T. Uchiyama, and T. Hori
Nitric Oxide Inhibits IFN-{alpha} Production of Human Plasmacytoid Dendritic Cells Partly via a Guanosine 3',5'-Cyclic Monophosphate-Dependent Pathway
J. Immunol., July 15, 2005; 175(2): 806 - 812.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Schlender, V. Hornung, S. Finke, M. Gunthner-Biller, S. Marozin, K. Brzozka, S. Moghim, S. Endres, G. Hartmann, and K.-K. Conzelmann
Inhibition of Toll-Like Receptor 7- and 9-Mediated Alpha/Beta Interferon Production in Human Plasmacytoid Dendritic Cells by Respiratory Syncytial Virus and Measles Virus
J. Virol., May 1, 2005; 79(9): 5507 - 5515.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Marcenaro, M. D. Chiesa, F. Bellora, S. Parolini, R. Millo, L. Moretta, and A. Moretta
IL-12 or IL-4 Prime Human NK Cells to Mediate Functionally Divergent Interactions with Dendritic Cells or Tumors
J. Immunol., April 1, 2005; 174(7): 3992 - 3998.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. McKenna, A.-S. Beignon, and N. Bhardwaj
Plasmacytoid Dendritic Cells: Linking Innate and Adaptive Immunity
J. Virol., January 1, 2005; 79(1): 17 - 27.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.